Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA5oK7bpcryDSbZ6zvZk83Lin4XtwkJoycpZHHV8mV-vI#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Administration of Mifepristone tablets, 200mg and misoprostol for the termination of pregnancy (the ""treatment procedure"") is contraindicated in patients with any of the following conditions: - [ see Warnings and Precautions ( 5.4 - - - [ see Adverse Reactions ( 6.2 - - Use of Mifepristone tablets, 200mg and misoprostol for termination of intrauterine pregnancy is contraindicated in patients with an intrauterine device (""IUD"") in place (the IUD might interfere with pregnancy termination). If the IUD is removed, Mifepristone tablets, 200mg may be used. Confirmed/suspected ectopic pregnancy or undiagnosed adnexal mass ( 4 Chronic adrenal failure ( 4 Concurrent long-term corticosteroid therapy ( 4 History of allergy to mifepristone, misoprostol, or other prostaglandins ( 4 Hemorrhagic disorders or concurrent anticoagulant therapy ( 4 Inherited porphyria ( 4 Intrauterine device (IUD) in place ( 4"" assertion.
- association subject drugbank:DB00834 assertion.
- association predicate treats assertion.
- association object DOID_0060329 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00834 category Drug assertion.
- DOID_0060329 category Disease assertion.
- association provided_by NeuroDKG assertion.